Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery.

Author
Sharma, Mitesh
Nayar, Rahul
Graham, Yitka
Parretti, Helen M
Abbott, Sally
Tahrani, Abd
Miras, Alexander D
Madhok, Brijesh
Singhal, Rishi
Mahawar, Kamal
Publication date
2022-04-28
Subject
Biochemistry
Diseases & disorders of systemic, metabolic or environmental origin

Metadata
Show full item record
Abstract
No abstract available
Citation
Sharma M, Nayar R, Graham Y, Parretti HM, Abbott S, Tahrani A, Miras AD, Madhok B, Singhal R, Mahawar K. Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery. Obes Surg. 2022 Jul;32(7):2469-2470. doi: 10.1007/s11695-022-06044-6. Epub 2022 Apr 28
Type
Article
Handle
http://hdl.handle.net/20.500.14200/2818
Additional Links
https://link.springer.com/journal/11695
DOI
10.1007/s11695-022-06044-6
PMID
35482224
Journal
Obesity Surgery
Publisher
Springer
Collections